NCT06281405 2026-04-03
TORCH-iTNT
Fudan University
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06304987 2024-03-19
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Beijing Friendship Hospital
Phase 2 Not yet recruiting
NCT05245474 2024-01-10
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2 Recruiting
NCT05845268 2023-05-06
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Beijing Friendship Hospital
Phase 2 Unknown